Georgina Maalouf

Statistics

Publications

Citations

1.4K

H-Index

Active since

2020

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Inserm

Sorbonne Université

Université Paris Cité

Pitié-Salpêtrière Hospital

Georgina Maalouf is an author at Assistance Publique – Hôpitaux de Paris specializing in pharmacotherapy, medicine, and acute respiratory distress syndrome.

ORCID

Publications per year

2020–2024

Publications

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14

Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema

Mathilde Leclercq, Anaïs Andrillon, Georgina Maalouf et al. · Ophthalmology · 2021 · 76 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients

Yves Allenbach, David Saadoun, Georgina Maalouf et al. · PLoS ONE · 2020 · 75 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +15

Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome

David Saadoun, Georgina Maalouf, Matheus Vieira et al. · NEJM Evidence · 2024 · 34 citations

Pharmacy, Immunology, Pharmacotherapy +12

1–5 of 9